Literature DB >> 1207292

[Cell cycle and carcinochemotherapy: reality or hope? (author's transl)].

H Ehrhart.   

Abstract

Different cytostatics interrupt the biochemical dynamics of tumor cells at different stages of the generation cycle, according to their mode of action. As a result of an additive or potentiated increase in efficiency, the therapeutic effect of each substrance can be improved by the use of suitable combinations in treating the treatment of carcinoma of the breast, carcinoma of the ovary, seminoma and other progressively swelling tumors. The difficulty in defining and interpreting quantitative parameters of concerous growths prevents the wider use of cytostatics.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1207292     DOI: 10.1007/bf01257500

Source DB:  PubMed          Journal:  Langenbecks Arch Chir        ISSN: 0023-8236


  8 in total

Review 1.  Adriamycin. A new anticancer drug with significant clinical activity.

Authors:  R H Blum; S K Carter
Journal:  Ann Intern Med       Date:  1974-02       Impact factor: 25.391

2.  [Treatment of advanced inoperable carcinoma of the ovaries (author's transl)].

Authors:  H J Senn
Journal:  Ther Umsch       Date:  1973-09

3.  [Endocrine and cytostatic treatment of metastazing breast carcinoma in the female].

Authors:  H Nowakowski
Journal:  Strahlentherapie       Date:  1974-04

4.  [Cellkinetic studies on Ehrlich-ascites tumor by treatment with vincristine].

Authors:  R Hartenstein; H Ehrhart; K Hoffmann
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1973-05-07

5.  Hormonal therapy of renal carcinoma alone and in association with cytostatic drugs.

Authors:  P Alberto; H J Senn
Journal:  Cancer       Date:  1974-05       Impact factor: 6.860

6.  Phase II evaluation of adriamycin in human neoplasia.

Authors:  R M O'Bryan; J K Luce; R W Talley; J A Gottlieb; L H Baker; G Bonadonna
Journal:  Cancer       Date:  1973-07       Impact factor: 6.860

7.  Proceedings: Chemotherapy of adenocarcinoma of the kidney.

Authors:  R W Talley
Journal:  Cancer       Date:  1973-11       Impact factor: 6.860

8.  [Chemotherapy of metastasizing breast cancers. Indications and results].

Authors:  W M Gallmeier; U Bruntsch; C G Schmidt
Journal:  Dtsch Med Wochenschr       Date:  1975-01-10       Impact factor: 0.628

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.